Approvals/TGA/ABRAXANE nanoparticle albumin-bound paclitaxel 100 mg powder for injection (suspension) vial

Approved

STANDARD

ABRAXANE nanoparticle albumin-bound paclitaxel 100 mg powder for injection (suspension) vial

Abraxis BioScience Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 357f702a29887a61
Product Name: ABRAXANE nanoparticle albumin-bound paclitaxel 100 mg powder for injection (suspension) vial
Artg Id: 133500
Artg Name: ABRAXANE nanoparticle albumin-bound paclitaxel 100 mg powder for injection (suspension) vial
Sponsor: Abraxis BioScience Australia Pty Ltd
Company Detail Path: /organization/abraxis-bioscience-australia-pty-ltd
Artg Date: 2008-10-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/9fb66685a692513533087a1de1c36e73.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/70eb934707674328af557859f3674fd8.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

357f702a29887a61

Type

Standard